Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

14%

1 of 7 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
7(100.0%)
7Total
N/A(7)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT06846827Not ApplicableCompleted

Cognitive, Mood, Anti-Inflammatory and Metabolic Effects of Chronic Oyster Mushroom Intervention in Older Adults

Role: collaborator

NCT04257201Not ApplicableCompleted

Mushroom Ingestion Study

Role: collaborator

NCT04259229Not ApplicableCompleted

Mediterranean Diet and Mushrooms

Role: collaborator

NCT05594329Not ApplicableCompleted

Neurological, Inflammatory and Metabolic Effects of Acute Mushroom Intervention in Older Adults

Role: collaborator

NCT00198770Not ApplicableCompleted

Dietary Compensation With Substitution of Meat Products With White Button Mushrooms.

Role: collaborator

NCT01177085Not ApplicableCompleted

Substituting Mushrooms for Meat to Control Body Weight

Role: collaborator

NCT01398176Not ApplicableCompleted

Immune Benefits From Mushroom Consumption

Role: collaborator

All 7 trials loaded